Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-004506

PRESIDENT AND CEO gave up 66,166 shares (to pay taxes)

  • PRESIDENT AND CEO acquired 122,786 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Torley Helen PRESIDENT AND CEO 2025-02-15 Option exercise +13,092 679,836 D
Torley Helen PRESIDENT AND CEO 2025-02-15 Shares withheld for taxes −7,098 $58.29 $413,742 672,738 D
Torley Helen PRESIDENT AND CEO 2025-02-16 Option exercise +71,810 744,548 D
Torley Helen PRESIDENT AND CEO 2025-02-16 Shares withheld for taxes −38,668 $58.29 $2,253,958 705,880 D
Torley Helen PRESIDENT AND CEO 2025-02-16 Option exercise +21,009 726,889 D
Torley Helen PRESIDENT AND CEO 2025-02-16 Shares withheld for taxes −11,313 $58.29 $659,435 715,576 D
Torley Helen PRESIDENT AND CEO 2025-02-16 Option exercise +16,875 732,451 D
Torley Helen PRESIDENT AND CEO 2025-02-16 Shares withheld for taxes −9,087 $58.29 $529,681 723,364 D
Derivatives
Torley Helen PRESIDENT AND CEO 2025-02-15 Option exercise · Restricted Stock Units −13,092 0 D
Torley Helen PRESIDENT AND CEO 2025-02-16 Option exercise · Performance Stock Units −71,810 0 D
Torley Helen PRESIDENT AND CEO 2025-02-16 Option exercise · Restricted Stock Units −21,009 21,009 D
Torley Helen PRESIDENT AND CEO 2025-02-16 Option exercise · Restricted Stock Units −16,875 33,749 D
Loading xslF345X05/form4-02182025_110248.xml…